SI
CORT icon

Shaker Investments’s Corcept Therapeutics CORT Stock Holding History

Shaker Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,648
Closed -$469K – 86
2025
Q3 		$469K Sell
5,648
-1,328
-19% -$96.1K 0.19% 75
2025
Q2 		$512K Buy
6,976
+2,902
+71% +$210K 0.21% 78
2025
Q1 		$465K Buy
+4,074
New +$248K 0.22% 73
2018
Q3 		– Sell
-107,640
Closed -$1.69M – 71
2018
Q2 		$1.69M Sell
107,640
-30
-0% -$522 1.04% 33
2018
Q1 		$1.77M Sell
107,670
-20,215
-16% -$375K 1.1% 29
2017
Q4 		$2.31M Buy
127,885
+13,800
+12% +$250K 1.53% 21
2017
Q3 		$2.2M Buy
+114,085
New +$1.7M 1.53% 21

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shaker Investments's CORT Position: Q4 2025 in Review

Shaker Investments sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 5,648 shares — an estimated $469K sold.

Shaker Investments first reported a position in CORT in Q3 2017 and held it in 7 quarters. The position peaked at $2.31M in Q4 2017. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Shaker Investments reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Shaker Investments sold 5,648 Corcept Therapeutics shares in Q4 2025, an estimated $469K.
  • Shaker Investments first reported a position in Corcept Therapeutics in Q3 2017 and held it in 7 quarters.
  • Shaker Investments's Corcept Therapeutics position peaked at $2.31M in Q4 2017.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Shaker Investments's 13F filing for Q4 2025, filed 30 Jan 2026.